-

Coty Launches Scientific Advisory Board on Skincare Innovation

MONACO--(BUSINESS WIRE)--Coty Inc. (NYSE: COTY)(Paris: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, skin and body care, proudly announces the launch of its first Scientific Advisory Board, following the inaugural meeting on September 24, 2024.

The Advisory Board brings together globally renowned scientific experts from diverse technical disciplines, selected for their unique expertise and contribution to cutting-edge research. The Board will convene twice a year to inform and inspire breakthrough innovations within Coty’s R&D specialists, and therefore strengthen Coty’s efforts to shape the future of skincare.

The first meeting, held at Coty’s Skincare Research & Innovation Center of Excellence in Monaco, brought together these leading scientists to discuss the current themes in skin health and skin repair. The experts provided valuable insights and feedback that will continue to shape Coty’s R&D initiatives and product innovation strategies across all its skincare brands.

Sue Nabi, CEO of Coty, said: “This year marks our 120th anniversary as pioneers in the beauty industry, and I’m honored that such acclaimed scientific minds have agreed to come together to help define the future of Coty skincare as part of our Scientific Advisory Board. Each member has been carefully selected because they are at the forefront of their respective disciplines. Their ongoing insights will play a pivotal role as we continue to collaborate and drive skincare innovation forward for the benefit of all our consumers.”

The Scientific Advisory Board will serve as a forum for the exchange of cutting-edge ideas, innovative thinking, and rigorous challenge. In line with Coty’s commitment to co-creation, the board will align the latest science with emerging trends and consumer needs, which will enhance Coty’s leading position in skin science.

Appropriately, the inaugural meeting of the Scientific Advisory Board took place at Coty’s Center of Excellence in Monaco, where one of the company’s flagship skincare brands was founded 70 years ago.

Members of Coty’s Scientific Advisory Board

Dr. Miriam Merad, MD, PhD – Director of Precision Immunology Institute - New York
Dr. Emma Guttman, MD, PhD – Professor of Dermatology & Immunology - New York
Dr. Patrick Bui, MD – Head of Plastic Surgery Department American Hospital - Paris
Pr. Selim Aractingi, MD, PhD – Team Leader, Cutaneous Biology Labs, Cochin Institute - Paris
Pr. Wei Liu, MD, PhD – Dermatologist - Beijing
Pr. Deng Xingwang – Professor of Life Science - Beijing
Dr. Jaci Santana, MD – Dermatologist - Recife

About Coty Inc.

Founded in Paris in 1904, Coty is one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care. We serve consumers around the world, selling prestige and mass market products in more than 125 countries and territories. Coty and our brands empower people to express themselves freely, creating their own visions of beauty; and we are committed to protecting the planet. Learn more at coty.com or on LinkedIn and Instagram.

Contacts

Coty Inc.

NYSE:COTY

Release Versions

Contacts

Social Media Profiles
More News From Coty Inc.

Coty Announces Filing of Quarterly Report on Form 10-Q for the Fiscal Quarter Ended December 31, 2025

NEW YORK--(BUSINESS WIRE)--Regulatory News: Coty Inc. (NYSE: COTY) (EURONEXT PARIS: COTY) today announced that on February 5, 2026 the Company filed its quarterly report on Form 10-Q for the fiscal quarter ended December 31, 2025 with the U.S. Securities and Exchange Commission (the “SEC”). The quarterly report is available on the SEC’s website at: https://www.sec.gov/ix?doc=/Archives/edgar/data/0001024305/000102430526000014/coty-20251231.htm. About Coty Inc. Founded in Paris in 1904, Coty is o...

Coty Announces Second Quarter Fiscal Year 2026 Results

NEW YORK--(BUSINESS WIRE)--Regulatory News: Coty Inc. (NYSE: COTY) (Paris: COTY) ("Coty" or "the Company") today announced its results for the second quarter of fiscal year 2026, ended December 31, 2025. Coty delivered Q2 results broadly in line with expectations, while significantly reducing its net debt and leverage to the lowest level in close to a decade. “I'm truly excited and energized to join Coty at this pivotal moment," said Markus Strobel, Executive Chairman and Interim Chief Executiv...

Coty Enters Strategic Collaboration With OpenAI to Strengthen Responsible AI Adoption Across the Organization

NEW YORK--(BUSINESS WIRE)--Today, Coty Inc. (NYSE: COTY) (Paris: COTY) announces a strategic collaboration with OpenAI to expand the use of advanced artificial intelligence tools across selected areas of its global organization. With ChatGPT Enterprise, Coty employees will gain access to OpenAI’s most capable models with enterprise-grade security and privacy, supporting daily work and cross functional collaboration. This first phase gives targeted teams access to secure, enterprise grade AI too...
Back to Newsroom